Evidence map›Paper›PMID 28956852›Full record

ReviewInternational journal of environmental research and public health2017

Clinical Effects of Cigarette Smoking: Epidemiologic Impact and Review of Pharmacotherapy Options.

IfeanyiChukwu O Onor, Daniel L Stirling, Shandrika R Williams, Daniel Bediako, Amne Borghol, Martha B Harris, Tiernisha B Darensburg, Sharde D Clay, Samuel C Okpechi, Daniel F Sarpong

Open access · goldAbstract readReview
In one paragraph

Review in International journal of environmental research and public health, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 1 synthesis or guideline pooled it, 171 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Phytochemicals derived fromFrontiers in pharmacology · 2024
    Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

IfeanyiChukwu O OnorXavier University of Louisiana College of Pharmacy, 1 Drexel Drive, New Orleans, LA 70125, USA. ionor@xula.edu.
Daniel L StirlingXavier University of Louisiana College of Pharmacy, 1 Drexel Drive, New Orleans, LA 70125, USA. asori12@gmail.com.
Shandrika R WilliamsXavier University of Louisiana College of Pharmacy, 1 Drexel Drive, New Orleans, LA 70125, USA. srwillia@xula.edu.
Daniel BediakoXavier University of Louisiana College of Pharmacy, 1 Drexel Drive, New Orleans, LA 70125, USA. dannbetts@yahoo.com.
Amne BorgholXavier University of Louisiana College of Pharmacy, 1 Drexel Drive, New Orleans, LA 70125, USA. aborghol@xula.edu.
Martha B HarrisXavier University of Louisiana College of Pharmacy, 1 Drexel Drive, New Orleans, LA 70125, USA. mharris1@xula.edu.
Tiernisha B DarensburgXavier University of Louisiana College of Pharmacy, 1 Drexel Drive, New Orleans, LA 70125, USA. tbdarens@gmail.com.
Sharde D ClayXavier University of Louisiana College of Pharmacy, 1 Drexel Drive, New Orleans, LA 70125, USA. shardeclay@hotmail.com.
Samuel C OkpechiStanley S. Scott Cancer Center, School of Medicine, Louisiana State University Health Sciences Center New Orleans, 1700 Tulane Avenue, New Orleans, LA 70112, USA. samuelokpechi@gmail.com.
Daniel F SarpongCenter for Minority Health and Health Disparities Research and Education, Xavier University of Louisiana College of Pharmacy, 1 Drexel Drive, New Orleans, LA 70125, USA. dsarpong@xula.edu.
Xavier University of Louisiana · USLouisiana State University Health Sciences Center New Orleans · US

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI Peter Todd Katzmarzyk · 2012 to 2026
$69.1M
Xavier Pharmacy Endowment For Minority HealthS21MD000100 · NIMHD · XAVIER UNIVERSITY OF LOUISIANA · PI FRANCIS, NORMAN C. · 2001 to 2011
$39.0M
Xavier's RCMI Cancer Research ProgramG12MD007595 · NIMHD · XAVIER UNIVERSITY OF LOUISIANA · PI D'AMOUR, GENE · 2012 to 2018
$15.7M
NIGMS NIH HHS U54 GM104940NIMHD NIH HHS G12 MD007595NIMHD NIH HHS S21 MD000100
6 · The paper itself

Abstract

Cigarette smoking-a crucial modifiable risk factor for organ system diseases and cancer-remains prevalent in the United States and globally. In this literature review, we aim to summarize the epidemiology of cigarette smoking and tobacco use in the United States, pharmacology of nicotine-the active constituent of tobacco, and health consequence of cigarette smoking. This article also reviews behavioral and pharmacologic interventions for cigarette smokers and provides cost estimates for approved pharmacologic interventions in the United States. A literature search was conducted on Google Scholar, EBSCOhost, ClinicalKey, and PubMed databases using the following headings in combination or separately: cigarette smoking, tobacco smoking, epidemiology in the United States, health consequences of cigarette smoking, pharmacologic therapy for cigarette smoking, and non-pharmacologic therapy for cigarette smoking. This review found that efficacious non-pharmacologic interventions and pharmacologic therapy are available for cessation of cigarette smoking. Given the availability of efficacious interventions for cigarette smoking cessation, concerted efforts should be made by healthcare providers and public health professionals to promote smoking cessation as a valuable approach for reducing non-smokers' exposure to environmental tobacco smoke.

Indexed as

Tobacco Use CessationCigarette SmokingHumansNicotinePrevalenceUnited StatesNicotineadverse health effectscigarettenon-pharmacologic therapypharmacotherapysmokingtobacco

Identifiers

PMID28956852
PMCPMC5664648
OpenAlexW2756489063

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.